Dano Egamberdieva

19 та иш

1Tashkent Pediatric Medical Institute Tashkent, Republic of Uzbekistan

EFFECTS OF L - CARNITINE ON SYSTEMIC INFLAMMATION AND OXIDATIVE STRESS IN COVID-19 PATIENTS
Raimkulova Narina1, Daminov Botir1, Dano Egamberdieva +2
МақолаHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)20210 иқтибос
ABI
MO593: Study of Cardiopulmonal Parameters in Patients with CKD During Renal Rehabilitation
Durdona Saipova, Dano Egamberdieva
МақолаHealthcare Systems and Public HealthNephrology Dialysis Transplantation20220 иқтибос
ABI
#3421 MRI PREDICTORS OF DIASTOLIC DYSFUNCTION OF THE LEFT VENTRICLE
Dano Egamberdieva, Iroda Ruzmetova, Miao Yu +1
МақолаCardiovascular Function and Risk FactorsNephrology Dialysis Transplantation20230 иқтибос
ABI
#5764 STUDY OF THE INFLUENCE OF PHYSICAL ACTIVITY ON THE FUNCTION OF EXTERNAL RESPIRATION IN PATIENTS WITH CKD IN THE PROCESS OF REHABILITATION
Durdona Saipova, Iroda Ruzmetova, Dano Egamberdieva
МақолаHuman Health and DiseaseNephrology Dialysis Transplantation20230 иқтибос
ABI
#3423 DIAGNOSTIC SIGNIFICANCE MAGNETIC RESONANCE IMAGING IN CHRONIC HEART FAILURE OF VARIOUS GENESIS
Dano Egamberdieva, Iroda Ruzmetova, Mengmeng Yu +1
МақолаCardiac Imaging and DiagnosticsNephrology Dialysis Transplantation20230 иқтибос
ABI
#4977 ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH COVID-19 DURING ANTIOXIDANT THERAPY
Dano Egamberdieva, Iroda Ruzmetova, Narine Raimkulova
МақолаCOVID-19 Clinical Research StudiesNephrology Dialysis Transplantation20230 иқтибос
ABI
#5613 ASSESSMENT OF THE PROGRESSION OF CKD TAKING INTO ACCOUNT METABOLIC CHANGES
Guzal Karimdjanova, Dano Egamberdieva, Iroda Ruzmetova
МақолаCardiac, Anesthesia and Surgical OutcomesNephrology Dialysis Transplantation20230 иқтибос
ABI
Study of the comorbid background and features of the clinical course of chronic obstructive pulmonary disease (COPD) in combination with atrial fibrillation
Guzal Karimdjanova, Dano Egamberdieva
МақолаChronic Obstructive Pulmonary Disease (COPD) Research20230 иқтибос
ABI
#1534 Risk of CKD progression taken into account of metabolic changes
Dano Egamberdieva, Iroda Ruzmetova
МақолаDiet and metabolism studiesNephrology Dialysis Transplantation20240 иқтибос
ABI
#1146 Role of renal dysfunction in the use of anticoagulants in COPD patients with atrial fibrillation
Guzal Karimdjanova, Dano Egamberdieva, Iroda Ruzmetova
МақолаChronic Obstructive Pulmonary Disease (COPD) ResearchNephrology Dialysis Transplantation20240 иқтибос
ABI
#1533 The relationship between the severity of anemia, the level of inflammation markers and the dose of epoetin in patients in pre-dialysis stages of CKD
Dano Egamberdieva, Iroda Ruzmetova
МақолаErythropoietin and Anemia TreatmentNephrology Dialysis Transplantation20240 иқтибос
ABI
#1036 Studying the quality of life in patients with CKD during the short physical rehabilitation program
Durdona Saipova, Dano Egamberdieva, Iroda Ruzmetova
МақолаPeripheral Artery Disease ManagementNephrology Dialysis Transplantation20240 иқтибос
ABI
#1670 Gut-lung-kidney axis: gut microbiota and kidney disfunction in patients with COPD
Durdona Saipova, Dano Egamberdieva, Iroda Ruzmetova
МақолаGut microbiota and healthNephrology Dialysis Transplantation20250 иқтибос
ABI
INTESTINAL MICROBIOTA AND THE INFLAMMAGING PHENOMENON IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ROLE OF DYSBIOTIC DISORDERS IN MAINTAINING CHRONIC SYSTEMIC INFLAMMATION
Dano Egamberdieva, Shahnoza Akhmedova
МақолаGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
ABI
INTESTINAL MICROBIOTA AND THE INFLAMMAGING PHENOMENON IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ROLE OF DYSBIOTIC DISORDERS IN MAINTAINING CHRONIC SYSTEMIC INFLAMMATION
Dano Egamberdieva, Shahnoza Akhmedova
МақолаGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
ABI
MICROBIAL ANTIGENS AND HUMORAL IMMUNE RESPONSE IN RHEUMATOID ARTHRITIS: CURRENT STATE OF THE PROBLEM, ACHIEVEMENTS AND UNRESOLVED ISSUES.
Dano Egamberdieva, Shahnoza Akhmedova
МақолаRheumatoid Arthritis Research and TherapiesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
ABI
MICROBIAL ANTIGENS AND HUMORAL IMMUNE RESPONSE IN RHEUMATOID ARTHRITIS: CURRENT STATE OF THE PROBLEM, ACHIEVEMENTS AND UNRESOLVED ISSUES.
Dano Egamberdieva, Shahnoza Akhmedova
МақолаRheumatoid Arthritis Research and TherapiesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
ABI
THE ROLE OF DYSBIOTIC DISORDERS IN MAINTAINING CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
Dano Egamberdieva, Shahnoza Akhmedova
МақолаRheumatoid Arthritis Research and TherapiesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
ABI
THE ROLE OF DYSBIOTIC DISORDERS IN MAINTAINING CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
Dano Egamberdieva, Shahnoza Akhmedova
МақолаRheumatoid Arthritis Research and TherapiesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
ABI